ArticleScientific reports2024

Machine learning-based integration develops an immunogenic cell death-derived lncRNA signature for predicting prognosis and immunotherapy response in lung adenocarcinoma.

Jiazheng Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.